Adicet Bio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 27, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $51,000,000
Company Info
- Organizations Involved
- Novartis Venture Funds, Johnson & Johnson Innovation, Regeneron Pharmaceuticals
- Founders
- Aya Jakobovits
- Company Description
- Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies for cancer and other disease indications, with a focus on novel universal immune cell therapies (uICT).
- Market
- Cancer immunotherapy
- Location
- Menlo Park, California, USA
- Coinvestors
- Novartis Venture Funds, OrbiMed Advisors, Pontifax